Read + Share
Amedeo Smart
Independent Medical Education
Owada S, Endo H, Okada C, Yoshida K, et al. Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer. Anticancer Res 2020;40:5071-5079.PMID: 32878795
Email
LinkedIn
Facebook
Twitter
Privacy Policy